Target Price | $206.04 |
Price | $150.20 |
Potential |
37.18%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Krystal Biotech, Inc. 2026 .
The average Krystal Biotech, Inc. target price is $206.04.
This is
37.18%
register free of charge
$264.60
76.17%
register free of charge
$167.66
11.62%
register free of charge
|
|
A rating was issued by 18 analysts: 16 Analysts recommend Krystal Biotech, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Krystal Biotech, Inc. stock has an average upside potential 2026 of
37.18%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 290.52 | 390.25 |
473.02% | 34.33% | |
EBITDA Margin | 37.83% | 39.36% |
120.80% | 4.04% | |
Net Margin | 30.69% | 37.53% |
42.36% | 22.29% |
13 Analysts have issued a sales forecast Krystal Biotech, Inc. 2025 . The average Krystal Biotech, Inc. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Krystal Biotech, Inc. EBITDA forecast 2025. The average Krystal Biotech, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Krystal Biotech, Inc. Analysts have issued a net profit forecast 2025. The average Krystal Biotech, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 3.00 | 5.06 |
669.23% | 68.67% | |
P/E | 29.44 | |
EV/Sales | 9.30 |
14 Analysts have issued a Krystal Biotech, Inc. forecast for earnings per share. The average Krystal Biotech, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Krystal Biotech, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Chardan Capital |
Locked
➜
Locked
|
Locked | Aug 22 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 22 2025 |
Chardan Capital |
Locked
➜
Locked
|
Locked | Aug 05 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Aug 05 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
Chardan Capital |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Jul 22 2025 |
Analyst Rating | Date |
---|---|
Locked
Chardan Capital:
Locked
➜
Locked
|
Aug 22 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 22 2025 |
Locked
Chardan Capital:
Locked
➜
Locked
|
Aug 05 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Aug 05 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 25 2025 |
Locked
Chardan Capital:
Locked
➜
Locked
|
Jul 25 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Jul 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.